US cancer network recommending expensive drugs based on weak evidence, study finds

Study raises concerns about National Comprehensive Cancer Network, which publishes guidelines for American oncologists

Guidelines for American oncologists often recommend expensive and harmful cancer drugs for patients based on "weak evidence", according to a new study in the British Medical Journal.

Related: Cancer patients shed new light on rheumatoid arthritis